Lung Cancer in Women and Nonsmokers: What To Know About Symptoms, Diagnosis, and Treatment
“A recent study about the rates of lung cancer in younger women made some alarming headlines. That research found that lung cancer in women between the ages of 35 and 54 is more common than it is among men in the same age group.”
Advocacy and innovation: Acadiana man beats lung cancer thanks to personalized care at Our Lady of Lourdes
“Tommy Kiser knew something was wrong when the sharp pain on the left side of his back wouldn’t go away. He tried to dismiss it for a while, but when he had to leave a work assignment in Texas early to head home, he knew it was time to take action.”
Lung cancer survivor shares her story; why it’s so important to get screened
“BELLBROOK, Ohio (WKEF) — November is Lung Cancer Awareness Month, and the American Lung Association released a new study on Tuesday. It indicates that the survival rates for people who are diagnosed with lung cancer are improving, but not enough people are getting screened. The survival rate of those diagnosed has gone up 22% nationally, according to the study. Susan Verdier is a local woman who survived stage 3 lung cancer. Her message to people is simple; get screened early. It could be the difference between living and dying.”
Immunotherapy, Radiation Do Not Increase Necrosis in NSCLC Brain Tumors
“Treatment with immunotherapy and radiation has been shown to not increase the risk of radiation necrosis for patients with non-small cell lung cancer who have brain metastases, according to research.”
New understanding of lung cancer cells’ ‘memories’ suggests novel treatment approach
“A new understanding of lung cancer cells’ “memories” suggests a new strategy for improving treatment, Memorial Sloan Kettering Cancer Center (MSK) researchers have found.”
Promising ADCs Emerge in Non-Small Cell Lung Cancer
“Antibody-drug conjugates (ADCS) have emerged as a pillar of therapy across several advanced cancer types, including non–small cell lung cancer (NSCLC). However, beyond confirmatory phase 3 trials, questions about optimal agent sequencing, novel combinations, and management of their toxicities remain.”
Cancer center clinical trial gives lung cancer patients hope
“In 2011, Ben Xiang received the news no patient wants to hear. Not only did he have cancer, but he had lung cancer, the deadliest of cancers — and it was late stage. Xiang was diagnosed with non-small cell lung cancer, which had a five-year survival rate of only 9% at that time. He underwent surgery, chemotherapy and radiation. By 2017, his local oncologist told him that nothing more could be done. He had exhausted all treatment options unless he would like to try a clinical trial at UC Davis Comprehensive Cancer Center.”
